A new medical journal launched by the Independent Medical Alliance aims to counter what its founder describes as ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

The European pharmaceutical and biotechnology market offers vast opportunities. The European Pharmaceutical Directory aids businesses by providing up-to-date contact information, profiles, and ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic, according ...

The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% ...

By Michael Erman SAN FRANCISCO, Feb 11 (Reuters) - Some pharmaceutical companies not targeted by President Donald Trump for agreements to lower their U.S. drug pricing are looking to craft their own ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.

In Guzzardi’s view, it wasn’t a coincidence that the three no-shows accepted more campaign contributions from the drug industry than most other state lawmakers nationwide: Between $6,000 and $15,000 ...

Growth, value, or both?